Proteomic analysis of outer membrane vesicles from the probiotic strain Escherichia coli Nissle 1917

PROTEOMICS ◽  
2014 ◽  
Vol 14 (2-3) ◽  
pp. 222-229 ◽  
Author(s):  
Laura Aguilera ◽  
Lorena Toloza ◽  
Rosa Giménez ◽  
Antonia Odena ◽  
Eliandre Oliveira ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Outer Membrane ◽  
Proteomic Analysis ◽  
Membrane Vesicles ◽  
Probiotic Strain ◽  
Outer Membrane Vesicles ◽  
Escherichia Coli Nissle 1917 ◽  
Escherichia Coli Nissle

scholarly journals Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform

2021 ◽  
Vol 10 (4) ◽  
Author(s):  
Ilaria Zanella ◽  
Enrico König ◽  
Michele Tomasi ◽  
Assunta Gagliardi ◽  
Luca Frattini ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Outer Membrane ◽  
Membrane Vesicles ◽  
Outer Membrane Vesicles ◽  
Vaccine Platform

scholarly journals Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli

2006 ◽  
Vol 59 (1) ◽  
pp. 99-112 ◽  
Author(s):  
Carlos Balsalobre ◽  
Jose Manuel Silvan ◽  
Stina Berglund ◽  
Yoshimitsu Mizunoe ◽  
Bernt Eric Uhlin ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Outer Membrane ◽  
Membrane Vesicles ◽  
Outer Membrane Vesicles ◽  
Type I

scholarly journals Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7

2017 ◽  
Vol 61 (9) ◽  
Author(s):  
Andreas Bauwens ◽  
Lisa Kunsmann ◽  
Helge Karch ◽  
Alexander Mellmann ◽  
Martina Bielaszewska
Keyword(s):  
Escherichia Coli ◽  
Outer Membrane ◽  
Shiga Toxin ◽  
Membrane Vesicles ◽  
Polymyxin B ◽  
Outer Membrane Vesicles ◽  
Enterohemorrhagic Escherichia Coli ◽  
Content Type ◽  
E Coli ◽  
Major Virulence Factor

ABSTRACT Ciprofloxacin, meropenem, fosfomycin, and polymyxin B strongly increase production of outer membrane vesicles (OMVs) in Escherichia coli O104:H4 and O157:H7. Ciprofloxacin also upregulates OMV-associated Shiga toxin 2a, the major virulence factor of these pathogens, whereas the other antibiotics increase OMV production without the toxin. These two effects might worsen the clinical outcome of infections caused by Shiga toxin-producing E. coli. Our data support the existing recommendations to avoid antibiotics for treatment of these infections.

Sign in / Sign up

Export Citation Format

Share Document